After years of anticipation, we might finally be getting a Bitcoin ETF. This development, which could potentially drive trillions of dollars into the crypto market, still feels surreal to many. However, with SEC progress, spot Bitcoin ETFs are getting closer and might be launched in January. Meanwhile, InQubeta (QUBE) is nearing $7 million in presale after raising over $6.8 million so far.
This post will cover the impending approval of a Bitcoin ETF by the SEC. Further, it will discuss the factors driving demand for an AI altcoin, InQubeta, explaining why it is one of the best coins to invest in.
InQubeta (QUBE): The Best ICO
It has been a great year for InQubeta (QUBE), whose presale launched in the second half of 2023. Following the raise of more than $6.8 million in its presale, it has cemented its position as 2023’s best ICO. With its sights set on the $7 million fundraising milestone next, it is one of the altcoins to watch.
The overwhelming surge in presale participation is due to its groundbreaking concept and explosive growth potential. It stands at the intersection of AI and blockchain, which are two of the world’s most transformative innovations. Therefore, it has been able to create a bullish narrative, with its adoption imminent.
Its innovative concept involves reshaping the fundraising landscape of the AI industry. It aims to become the first crowdfunding platform for AI startups through crypto. This novel platform will allow AI tech startups to source funds by creating investment opportunities, which will be represented as NFTs.
Given the above, it is the best new crypto to invest in. The presale is in its sixth stage, and according to industry experts, it will skyrocket. At its current stage, a token costs just $0.01925 and has been tipped for 4,500% growth after launch. If you wish to participate in this exciting presale, simply follow the link below.
Bitcoin (BTC): SEC Approval of ETF Appears to be Imminent
The timeline for the approval of a Bitcoin ETF grows closer. In light of the recent positive developments from the US Securities and Exchange Commission (SEC) quarters, approval is a matter of when and not if.
According to popular forecasts, spot Bitcoin ETFs will be launched in January. The ARK 21Shares Bitcoin ETF approval deadline with the SEC is January 10. Hence, it is widely believed that its application will be approved along with other ETF filings.
Further, the SEC has been active in its discussions. The agency has been commenting on issuer filings, with several applications updated in the past few weeks. Additionally, regulatory specifics have also been discussed with issuers. These back-and-forth discussions illustrate progress towards approval.
Bitcoin (BTC) has been soaring in anticipation of this approval, shooting past $40,000. The excitement around the approval of a Bitcoin ETF has driven up the value of the best cryptocurrency (BTC). With trillions of dollars to flow into the Bitcoin and overall crypto markets, BTC is positioned as the best crypto to invest in.
Conclusion
A Bitcoin ETF is closer to being approved following the progress with the SEC. Additionally, another exciting development in the crypto scene is InQubeta, which is nearing $7 million in presales. At the moment, more than $6.7 million has been raised, and it has been gaining traction for another strong surge.
Blockzeit Disclaimer: This article is sponsored. Blockzeit does not endorse and is not responsible for or liable for any content, accuracy, quality, advertising, products, or other materials on this page. Readers should conduct their own research before taking any actions related to the advertised project. Blockzeit is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods, or services mentioned in the press release. This article is provided for informational purposes only and is not intended as investment advice. The content does not constitute a recommendation to buy, sell, or hold any securities or financial instruments. Readers should conduct their own research and consult with financial advisors before making investment decisions. The information presented may not be current and could become outdated.
By accessing and reading this article, you acknowledge and agree to the above disclosure and disclaimer.